Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria Teixeira has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Medico-Economic and Medico-Social Evaluation of Two Types of Treatment for Clubfoot in France: A Prospective Study Using a Mixed Methods Approach

    by Anaïs Le Jeannic, Belkacem Zenati, Clément Picot-Ngo, Sophie Guilmin-Crépon, Maria Texeira, Agathe Turpin, Priscilla Boizeau, Arnaud Nze Ossima, Corinne Alberti, Isabelle Durand-Zaleski, et al.

    Background/Objectives: Congenital clubfoot is the most frequent malformation in pediatric orthopedics. In France, two treatments can be proposed: the Ponseti method and the functional method. The objective was to conduct a medico-economic and -social evaluation of those methods. Methods: Medico-economic: a cost-consequences analysis was undertaken from the societal perspective, based on the Dimeglio score at 24 months in four pediatric hospitals. Medico-social: interviews were conducted with parents (n = 16) and healthcare professionals (n = 16). Results: One hundred patients were included between January 2014 and December 2016. Whatever the treatment method, over 90% of patients presented with benign clubfoot (i.e., Dimeglio score < 5/20) at 24 months, based on multiply imputed estimates. The Functional method was associated with higher direct medical and non-medical costs (€3340–4061 vs. 889–2318; €6275–5968 vs. 576–726), and indirect costs (€15,441–4672 vs. 1416–1786), contrary to out-of-pocket expenses (€0–1 vs. €322–546). Family testimonies underscored the importance of communication from healthcare providers to reassure and guide parents. Although the choice is influenced by professionals, trust and active engagement of families are essential for adherence to treatment and its long-term success. The Ponseti method combined effectiveness with a lower perceived burden for families. Conclusions: The Ponseti method was the costliest for parents, yet more manageable. However, the most important factor is to choose a method adapted to the family in order to achieve the best degree of compliance.

  • Intervention de prévention des conduites à risque en réseau d’éducation prioritaire

    by Clément Picot-Ngo, Maria Teixeira, Enora Le Roux, Paul Jacquin

    La « Mission Papillagou » (MP) est une action de prévention des conduites à risque dont le but est de développer les compétences psychosociales des collégien·ne·s. Une étude qualitative mobilisant des entretiens de groupe et des observations flottantes a été menée afin d’identifier les freins et les leviers de l’intervention pour atteindre cet objectif. Il s’agit à travers cet article de questionner les rapports sociaux qui sous-tendent la mise en oeuvre de l’intervention et d’identifier les enjeux qui en découlent. Sans prise en compte du contexte des interactions sociales asymétriques entre intervenant·e·s et élèves, la MP présente le risque de renforcer des identités stigmatisées.


  • Open Access

    COVID-19 Health Crisis and Chronic Illness: Protocol for a Qualitative Study

    by Élise Ricadat, Aude Béliard, Marie Citrini, Yann Craus, Céline Gabarro, Marie-France Mamzer, Ana Marques, Thomas Sannié, Maria Teixeira, Marko Tocilovac, et al.

    Background: The acute nature of the COVID-19 pandemic has put a strain on health resources that are usually dedicated to chronic illnesses. Resulting changes in care practices and networks have had major repercussions on the experience of people with chronic disorders. Objective: This paper presents the protocol of the Parcours, Associations, Réseau, Chronicité, Organisation, Usagers, Retour d’expérience, Soins (PARCOURS)-COVID study. The aim of this study is to evaluate the effects of reorganization of the health system on the usual care network of patients with chronic illness, which fosters and qualifies the quality and continuum of care provided. The first objective of this study is to document these patients’ experiences through transformations and adaptations of their network, both in the practical dimension (ie, daily life and care) and subjective dimension (ie, psychosocial experience of illness and relationship to the health system). The second objective of the study is to understand and acknowledge these reorganizations during the COVID-19 lockdown and postlockdown periods. The third objective is to produce better adapted recommendations for patients with chronic illness and value their experience for the management of future health crisis. Methods: The PARCOURS-COVID study is a qualitative and participatory research involving patient organizations as research partners and members of these organizations as part of the research team. Three group of chronic diseases have been selected regarding the specificities of the care network they mobilize: (1) cystic fibrosis and kidney disease, (2) hemophilia, and (3) mental health disorders. Four consecutive phases will be conducted, including (1) preparatory interviews with medical or associative actors of each pathology field; (2) in-depth individual interviews with patients of each pathology, analyzed using the qualitative method of thematic analysis; (3) results of both these phases will then be triangulated through interviews with members of each patient’s care ecosystem; and finally, (4) focus groups will be organized to discuss the results with research participants (ie, representatives of chronic disease associations; patients; and actors of the medical, psychosocial, and family care network) in a research-action framework. Results: The protocol study has undergone a peer review by the French National Research Agency’s scientific committee and has been approved by the research ethical committee of the University of Paris (registration number: IRB 00012020-59, June 28, 2020). The project received funding from August 2020 through April 2021. Expected results will be disseminated in 2021 and 2022. Conclusions: Our findings will better inform the stakes of the current health crisis on the management of patients with chronic illness and, more broadly, any future crisis for a population deemed to be at risk. They will also improve health democracy by supporting better transferability of knowledge between the scientific and citizen communities. International Registered Report Identifier (IRRID): DERR1-10.2196/28728


  • Open Access

    COVID-19 Health Crisis and Chronic Illness: Protocol for a Qualitative Study (Preprint)

    by Élise Ricadat, Aude Béliard, Marie Citrini, Yann Craus, Céline Gabarro, Marie-France Mamzer, Ana Marques, Thomas Sannié, Maria Teixeira, Marko Tocilovac, et al.

    BACKGROUND The acute nature of the COVID-19 pandemic has put a strain on health resources that are usually dedicated to chronic illnesses. Resulting changes in care practices and networks have had major repercussions on the experience of people with chronic disorders. OBJECTIVE This paper presents the protocol of the Parcours, Associations, Réseau, Chronicité, Organisation, Usagers, Retour d’expérience, Soins (PARCOURS)-COVID study. The aim of this study is to evaluate the effects of reorganization of the health system on the usual care network of patients with chronic illness, which fosters and qualifies the quality and continuum of care provided. The first objective of this study is to document these patients’ experiences through transformations and adaptations of their network, both in the practical dimension (ie, daily life and care) and subjective dimension (ie, psychosocial experience of illness and relationship to the health system). The second objective of the study is to understand and acknowledge these reorganizations during the COVID-19 lockdown and postlockdown periods. The third objective is to produce better adapted recommendations for patients with chronic illness and value their experience for the management of future health crisis. METHODS The PARCOURS-COVID study is a qualitative and participatory research involving patient organizations as research partners and members of these organizations as part of the research team. Three group of chronic diseases have been selected regarding the specificities of the care network they mobilize: (1) cystic fibrosis and kidney disease, (2) hemophilia, and (3) mental health disorders. Four consecutive phases will be conducted, including (1) preparatory interviews with medical or associative actors of each pathology field; (2) in-depth individual interviews with patients of each pathology, analyzed using the qualitative method of thematic analysis; (3) results of both these phases will then be triangulated through interviews with members of each patient’s care ecosystem; and finally, (4) focus groups will be organized to discuss the results with research participants (ie, representatives of chronic disease associations; patients; and actors of the medical, psychosocial, and family care network) in a research-action framework. RESULTS The protocol study has undergone a peer review by the French National Research Agency’s scientific committee and has been approved by the research ethical committee of the University of Paris (registration number: IRB 00012020-59, June 28, 2020). The project received funding from August 2020 through April 2021. Expected results will be disseminated in 2021 and 2022. CONCLUSIONS Our findings will better inform the stakes of the current health crisis on the management of patients with chronic illness and, more broadly, any future crisis for a population deemed to be at risk. They will also improve health democracy by supporting better transferability of knowledge between the scientific and citizen communities. CLINICALTRIAL Institutional Review Board 00012020-59 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/28728